Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Exploratory endpoints (arbitrary tests)

MK Masahiro Katsuda
MM Motoki Miyazawa
TO Toshiyasu Ojima
AK Akio Katanuma
KH Kenichi Hakamada
KS Kentaro Sudo
SA Shingo Asahara
IE Itaru Endo
MU Makoto Ueno
KH Kazuo Hara
SY Suguru Yamada
TF Tsutomu Fujii
SS Sohei Satoi
TI Tatsuya Ioka
MO Masaichi Ohira
TA Takahiro Akahori
MK Masayuki Kitano
HN Hiroaki Nagano
MF Masayuki Furukawa
TA Tomohiko Adachi
HY Hiroki Yamaue
ask Ask a question
Favorite

The following tests related to the exploratory endpoints are performed in specific trial sites where the tests are available. Informed consent is obtained from patients before performing any tests:

WT1-specific CTL (enzyme-linked immuno spot, tetramer)

Intestinal flora test (fecal examination)

Quality of life survey (European Organization for Research and Treatment of Cancer QLQ-C30, EuroQol 5 dimension 5 level [EQ-5D-5 L])

Investigation of tumor local environment

Analysis of systemic milieu in study patients

Analysis of the investigational product

Copyright and License information: The Author(s). ©2019
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A